SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

ASPC is trending due to extreme price volatility and massive trading volume, fueled by speculation around its low float and high borrow rate. The community is actively debating a potential short squeeze, comparing its wild swings to past parabolic runners, while others warn of a pump and dump scenario, highlighting its nature as a high-risk SPAC play.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp (OMER) is trending following the recent FDA approval of YARTEMLEA, its first-in-class treatment for transplant-associated thrombotic microangiopathy, addressing a severe condition with no current alternatives. The community is actively discussing the significant revenue potential from this market monopoly and the company's strengthened financial position due to a major partnership and debt reduction. Investors are keenly awaiting the upcoming conference call for further commercialization details and potential additional catalysts.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its exceptionally active and dedicated community, which consistently emphasizes strong conviction and relentless real-world brand building. Discussions highlight ongoing initiatives to launch diverse IRL products and ventures, such as energy drinks, merchandise, and a spice brand. This positions KENDU as a unique decentralized brand focused on long-term growth and an expanding global presence.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as traders navigate expectations of a year-end rally and anticipated Federal Reserve rate cuts, driving significant bullish speculation in the tech-heavy Nasdaq. The recent 2-for-1 stock split has sparked community debate, with many seeing it as a potential catalyst for renewed buying interest, while others express caution regarding amplified market volatility and the long-term sustainability of the AI-driven rally. Sentiment remains divided, balancing aggressive upside bets against concerns over leveraged exposure in a dynamic market.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing a significant surge, driven by escalating concerns over diminishing global supply, particularly with China's impending silver export restrictions, meeting heightened industrial demand for critical technologies. This price action has ignited intense debate among investors, with bulls celebrating a potential 'silver squeeze' and a long-overdue revaluation of the metal, while bears warn of a parabolic 'blow-off top' and an imminent correction.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending following recent strong earnings and strategic moves, including an acquisition that expands its defense capabilities, driving renewed optimism. The community is actively debating its valuation after a significant post-IPO pullback, with many anticipating future catalysts from upcoming launches and potential lucrative government contracts within the burgeoning space sector.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is making significant waves in the cybersecurity landscape, driven by an expanded multi-year partnership with Google Cloud focused on AI security and recent strategic acquisitions. The community is buzzing with discussions on its long-term growth potential in a booming sector, even as some traders evaluate recent price movements as a compelling buy-the-dip opportunity for this platform leader.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending due to strong Black Friday-Cyber Monday sales figures and robust recent earnings, showcasing impressive growth in merchant solutions and gross merchandise volume. The community is actively discussing its expanding AI ecosystem and strategic positioning within the e-commerce sector, anticipating continued momentum through the holiday season.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

AIRCOIN is trending amidst strong community adoption of its innovative "AirLock" initiative, which has led to a significant portion of the token's supply being locked up by holders. This focus on "community-owned supply control" is generating widespread bullish sentiment, with many believing it marks a revolutionary approach for memecoins on Solana and anticipate substantial future movement.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is a key trending topic following a significant $600 million financing injection and a substantial 1-for-30 reverse stock split. While the financing aims to bolster its financial position, the community is vocally divided, with many seeing the reverse split as a tactic masking deeper concerns about dilution, cash burn, and management's ability to drive profitability in the challenging EV landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oncobiologics (NASDAQ:OTLK) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst Says

Ascendiant Capital Markets upped their target price on shares of Oncobiologics from $8.00 to $10.00 and gave the company a "buy" rating in a research note on Monday...

Oncobiologics (NASDAQ:OTLK) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Oncobiologics from a "strong sell" rating to a "hold" rating in a research note on Saturday...

Oncobiologics, Inc. (OTLK) Reports Q4 Loss, Lags Revenue Estimates

Oncobiologics (OTLK) delivered earnings and revenue surprises of +4.35% and -101.50%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Oncobiologics (NASDAQ:OTLK) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Oncobiologics (NASDAQ:OTLK - Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of...

Oncobiologics (OTLK) Expected to Announce Quarterly Earnings on Friday

Oncobiologics (NASDAQ:OTLK) will be releasing its Q4 2025 earnings before the market opens on Friday, December 26. (View Earnings Report at...

Oncobiologics, Inc. (NASDAQ:OTLK) Given Average Rating of "Hold" by Analysts

Shares of Oncobiologics, Inc. (NASDAQ:OTLK - Get Free Report) have been given an average rating of "Hold" by the six brokerages that are currently covering the stock, Marketbeat reports. One...

Oncobiologics (NASDAQ:OTLK) Stock Price Up 4.6% - Still a Buy?

Oncobiologics (NASDAQ:OTLK) Shares Up 4.6% - Time to Buy...

Oncobiologics (NASDAQ:OTLK) Trading Up 5.9% - Still a Buy?

Oncobiologics (NASDAQ:OTLK) Trading Up 5.9% - Should You Buy...

OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug

Outlook Therapeutics stock plunges 54% after the FDA rejects ONS-5010 BLA again, citing lack of efficacy data in confirmatory study.

Outlook Therapeutics, Inc. (OTLK) announced on Thursday that the U.S. Food and Drug Administration (FDA) has declined to approve its investigational drug Lytenava for the treatment of wet age-related macular degeneration. Shares of the company nosedived by over 66% in Thursday’s pre-market session following the announcement.The agency cited a lack of substantial evidence of effectiveness as the basis for its decision. Age-related macular degeneration causes damage to the macula, a small area near the center of the retina, which is the part of the eye responsible for sharp, central vision. It is common among people aged 50 and older. Wet age-related macular degeneration (wet AMD) is an advanced form of AMD where abnormal, leaky blood vessels grow under the retina, leading to rapid vision loss.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/OTLK">OTLK stock</a> trended within ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.The agency <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/08/28/3140631/0/en/Outlook-Therapeutics-Provides-Regulatory-Update-on-U-S-Food-and-Drug-Administration-Review-of-ONS-5010-LYTENAVA-bevacizumab-vikg-for-the-Treatment-of-Wet-AMD.html">noted</a> in its letter to the company that the drug did not meet the primary efficacy endpoint in a study and recommended that confirmatory evidence of efficacy be submitted to support the application.CEO Bob Jahr said that the company is very disappointed with this outcome and intends to meet with the agency to receive additional clarity on requirements for approval.“It is important to also note that the CRL (letter) identified no other outstanding deficiencies in our BLA (application),” Jahr added.The company also said that it intends to continue its efforts to expand Lytenava into additional markets in Europe. It has already been granted Marketing Authorization by the European Commission in the European Union and Marketing Authorization by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK for the treatment of wet AMD.OTLK is up by 26% this year but down by 68% over the past 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lisa-cook-to-sue-trump-administration-firing-her-federal-reserve-board/chsH6GARdjs">Lisa Cook To Sue Trump Administration For Firing Her From Federal Reserve Board: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Outlook Therapeutics Stock Nose-Dives 66% In Pre-Market – Here’s Why

The US FDA declined to approve the firm’s investigational drug Lytenava for the treatment of wet age-related macular degeneration, citing a lack of substantial evidence of effectiveness.

Equity

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

OTLK
Outlook Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OTLK News

OTLKOutlook Therapeutics Inc